Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.

about

CMML: Clinical and molecular aspects.TRIM proteins in blood cancers.Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice.Chronic Myelomonocytic Leukemia following Multicentric Castleman Disease.

P2860

Q38689508-52C1870B-21F2-4D3E-8CCA-1AF55C3340E7 Q47433060-A78A7E5C-44BD-44EF-B4B1-7F32DC8D7116 Q48134669-C4841FC9-E675-422B-B8FF-C9F0406A153F Q52614425-421A9B3D-14D2-41A7-B9C8-B61E94A380A0

P2860

Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.

Item

http://www.wikidata.org/entity/Q38859646

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.

@en

type

Item

label

Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.

@en

prefLabel

Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.

@en

P1476

Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.

@en

P2093

Ana Alfonso

http://www.w3.org/2001/XMLSchema#string

Carlos Bueso-Ramos

http://www.w3.org/2001/XMLSchema#string

Elias J Jabbour

http://www.w3.org/2001/XMLSchema#string

Guillermo Montalban-Bravo

http://www.w3.org/2001/XMLSchema#string

Koichi Takahashi

http://www.w3.org/2001/XMLSchema#string

Naveen Pemmaraju

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Chronic myelomonocytic leukemia

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

Proposals for the classification of the myelodysplastic syndromes

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

International scoring system for evaluating prognosis in myelodysplastic syndromes

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System

P304

599-606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.24735

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guillermo Garcia-Manero

Sherry Pierce

Marina Konopleva

P577

2017-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28370097

http://www.w3.org/2001/XMLSchema#string

P932

5553721

http://www.w3.org/2001/XMLSchema#string

Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.

about

P2860

P2860

Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932